SG10201808645TA - Fortified Micronutrient Salt Formulations - Google Patents

Fortified Micronutrient Salt Formulations

Info

Publication number
SG10201808645TA
SG10201808645TA SG10201808645TA SG10201808645TA SG10201808645TA SG 10201808645T A SG10201808645T A SG 10201808645TA SG 10201808645T A SG10201808645T A SG 10201808645TA SG 10201808645T A SG10201808645T A SG 10201808645TA SG 10201808645T A SG10201808645T A SG 10201808645TA
Authority
SG
Singapore
Prior art keywords
micronutrients
salt
sensitive
formulations
stomach
Prior art date
Application number
SG10201808645TA
Inventor
Ana Jaklenec
Xian Xu
Lowell Wood
Andrew Welkhoff Philip
William Gates
Boris Nikolic
Robert Langer
Original Assignee
Massachusetts Inst Technology
Tokitae Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology, Tokitae Llc filed Critical Massachusetts Inst Technology
Publication of SG10201808645TA publication Critical patent/SG10201808645TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/74—Fixation, conservation, or encapsulation of flavouring agents with a synthetic polymer matrix or excipient, e.g. vinylic, acrylic polymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

FORTIFIED MICRONUTRIENT SALT FORMULATIONS Salt formulations, which are resistant to moisture and cooking conditions, are described herein. The formulations provide particles of micronutrients and vitamins encapsulated within heat resistant pH-sensitive water-insoluble polymers, which are packaged 5 within a salt shell. The pH-sensitive, water-insoluble, thermally stable materials stabilize the micronutrients, particularly at high temperatures, such as during food preparation and cooking, and release the micronutrients at the desired locations such as the stomach, small intestine, etc. Preferred pH-sensitive polymers release at a low pH, less than the pH present in the stomach. The particles can be used to deliver daily-recommended doses of micronutrients 10 simultaneously with salt, eliminating the need for vitamin pills. This is particularly important in populations suffering from severe malnutrition. Figure 1
SG10201808645TA 2013-12-16 2014-12-16 Fortified Micronutrient Salt Formulations SG10201808645TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361916485P 2013-12-16 2013-12-16
US201462036405P 2014-08-12 2014-08-12
US201462066551P 2014-10-21 2014-10-21

Publications (1)

Publication Number Publication Date
SG10201808645TA true SG10201808645TA (en) 2018-11-29

Family

ID=52293246

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201808645TA SG10201808645TA (en) 2013-12-16 2014-12-16 Fortified Micronutrient Salt Formulations
SG11201604805XA SG11201604805XA (en) 2013-12-16 2014-12-16 Fortified micronutrient salt formulations

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201604805XA SG11201604805XA (en) 2013-12-16 2014-12-16 Fortified micronutrient salt formulations

Country Status (7)

Country Link
US (3) US9649279B2 (en)
EP (1) EP3082471B1 (en)
CN (1) CN106061292B (en)
ES (1) ES2647791T3 (en)
MX (1) MX2016007786A (en)
SG (2) SG10201808645TA (en)
WO (1) WO2015095185A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201808645TA (en) * 2013-12-16 2018-11-29 Massachusetts Inst Technology Fortified Micronutrient Salt Formulations
FR3042387B1 (en) * 2015-10-20 2019-05-24 Ynsect PRESERVATION OF WATER-SOLUBLE VITAMINS
EP3368010B1 (en) * 2015-10-26 2025-12-10 Blaesi, Aron H. Solid dosage form immediate drug release and apparatus and method for manufacture thereof
US11129798B2 (en) 2016-08-19 2021-09-28 Aron H. Blaesi Fibrous dosage form
ES2706101A1 (en) * 2017-09-26 2019-03-27 Liofilizados Girona S L Method for obtaining microcapsules, microcapsules obtained by the same, and nutraceutical or pharmaceutical compositions comprising said microcapsules (Machine-translation by Google Translate, not legally binding)
CN107712909A (en) * 2017-11-13 2018-02-23 济川药业集团有限公司 A kind of iron zinc Muti-vitamine Oral Solution
CN111801024A (en) * 2018-01-04 2020-10-20 麻省理工学院 Water-soluble and fat-soluble micronutrient-stabilized particles with an enteric polymer barrier
US20210015135A1 (en) * 2018-03-29 2021-01-21 Tata Chemicals Limited Encapsulated micronutrient granules for fortification of edible salt compositions
WO2020108812A1 (en) * 2018-11-26 2020-06-04 Purac Biochem B.V. Particulate food preservative composition
WO2020201908A1 (en) * 2019-04-01 2020-10-08 Tata Chemicals Limited Encapsulated micronutrient granules for fortification of edible salt compositions
GB201911105D0 (en) 2019-08-02 2019-09-18 Governing Council Of The Univ Of Toronto Multi-supplement food-additive
WO2021191926A1 (en) * 2020-03-23 2021-09-30 Aavishkar Oral Strips Private Limited Taste masked and rapidly disintegrating ultra thin iron orodispersible film and a process thereof
US20220046958A1 (en) * 2020-08-14 2022-02-17 Abt Health And Wellness Private Limited Fortified beverage composition and process of preparing thereof
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
AU2021391823A1 (en) 2020-12-03 2023-06-29 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
US12031128B2 (en) 2021-04-07 2024-07-09 Battelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
EP4503951A2 (en) * 2022-04-06 2025-02-12 Particles for Humanity, PBC Stabilized vitamin a and method of production
US20250319027A1 (en) * 2022-07-01 2025-10-16 Vitakey Inc. Nutraceutical particles
US20240299346A1 (en) * 2023-03-06 2024-09-12 Phi Health Sciences, Inc. Dietary supplement beads
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
WO2025122954A1 (en) 2023-12-08 2025-06-12 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182778A (en) * 1978-05-17 1980-01-08 General Foods Corporation Encapsulation of vitamin and mineral nutrients
KR920006865B1 (en) 1984-05-18 1992-08-21 워싱톤 유니버시티 테크놀러지 어소우시에이츠 인코오퍼레이티드 Method and apparatus for coating particles or liquid droplets
US4723958A (en) * 1986-05-23 1988-02-09 Merck & Co., Inc. Pulsatile drug delivery system
US5013716A (en) * 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
FR2659230A1 (en) 1990-03-08 1991-09-13 Rhone Poulenc Sante PROCESS FOR COATING A ACTIVE SENSITIVE PH POLYMER OF ACTIVE INGREDIENTS.
US5418010A (en) * 1990-10-05 1995-05-23 Griffith Laboratories Worldwide, Inc. Microencapsulation process
JP2893140B2 (en) * 1990-11-30 1999-05-17 エスエス製薬株式会社 Stable vitamin D preparation
US5490962A (en) 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
DK0724432T3 (en) 1993-10-22 2003-01-27 Genentech Inc Methods and compositions for microencapsulating antigens for use as vaccines
AU710504B2 (en) 1994-03-15 1999-09-23 Brown University Research Foundation Polymeric gene delivery system
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
ES2368824T3 (en) * 1998-03-27 2011-11-22 Oregon Health & Science University VITAMIN D AND ITS ANALOGS IN THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATIVE DISORDERS.
IN191070B (en) * 1998-05-28 2003-09-13 Internat Dev Res Ct
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
US6500463B1 (en) * 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
AU8015300A (en) 1999-10-12 2001-04-23 Ohio State University, The Reactive polymeric valve, dispensing devices and methods using same
US20040033241A1 (en) 2000-06-02 2004-02-19 Allergan, Inc. Controlled release botulinum toxin system
US6887493B2 (en) 2000-10-25 2005-05-03 Adi Shefer Multi component controlled release system for oral care, food products, nutraceutical, and beverages
EP1372708B1 (en) 2001-02-13 2008-06-18 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY Vaccine for transcutaneous immunization against travellers' diarrhoea
US7285289B2 (en) 2002-04-12 2007-10-23 Nagy Jon O Nanoparticle vaccines
WO2003092633A2 (en) 2002-05-06 2003-11-13 Massachusetts Institute Of Technology Diffusion-controlled dosage form and method of fabrication including three dimensional printing
US20040234579A1 (en) * 2003-05-22 2004-11-25 Mark D. Finke, Inc. Dietary supplements and methods of preparing and administering dietary supplements
CA2549539C (en) * 2003-12-15 2013-02-12 Council Of Scientific & Industrial Research Taste masked pharmaceutical composition comprising ph sensitive polymer
WO2005071088A2 (en) 2003-12-24 2005-08-04 Cerus Corporation Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
DE102005009241A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with controlled bioavailability
ES2421916T3 (en) * 2005-03-16 2013-09-06 Nycomed Gmbh Masked flavor pharmaceutical form containing roflumilast
US9205047B2 (en) * 2005-04-25 2015-12-08 The Governing Council Of The University Of Toronto Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
WO2006121819A1 (en) 2005-05-06 2006-11-16 Board Of Regents, The University Of Texas System Methods for fabricating nano and microparticles for drug delivery
KR20080024206A (en) 2005-06-20 2008-03-17 엘란 파마 인터내셔널 리미티드 Nanoparticulate Controlled Release Compositions Containing Aryl-Heterocyclic Compounds
CA2640460C (en) * 2006-01-27 2015-05-26 Eurand, Inc Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acids
EP2001446A2 (en) * 2006-03-13 2008-12-17 Encysive Pharmaceuticals, Inc Formulations of sitaxsentan sodium
CN104825397A (en) * 2006-04-03 2015-08-12 伊萨·奥迪迪 Controlled Release Delivery Devices Containing Organosol Coatings
US20080031927A1 (en) * 2006-07-11 2008-02-07 Catani Steven J Solid oral dosage vitamin and mineral compositions
US20080026040A1 (en) 2006-07-31 2008-01-31 Isaac Farr Active agent-releasing dosage forms
US20080075785A1 (en) * 2006-09-22 2008-03-27 San-Laung Chow Controlled release hydrogel formulation
WO2009023672A2 (en) * 2007-08-13 2009-02-19 Abuse Deterrent Pharmaceutical Llc Abuse resistant drugs, method of use and method of making
EP2217269B1 (en) 2007-10-12 2017-04-12 Massachusetts Institute of Technology Vaccine nanotechnology
US8563066B2 (en) * 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
US20110020519A1 (en) * 2008-01-04 2011-01-27 Aveka, Inc. Encapsulation of oxidatively unstable compounds
CA2716546A1 (en) 2008-02-25 2009-09-03 Novavax, Inc. Sugar glassified virus like particles (vlps)
JP5845173B2 (en) * 2009-05-01 2016-01-20 アデア ファーマスーティカルズ，インコーポレイテッド Orally disintegrating tablet composition comprising a combination of a non-opioid and an opioid analgesic
WO2011072208A1 (en) * 2009-12-10 2011-06-16 Monosol Rx, Llc Ph sensitive compounds in taste masking within oral thin film strips
EP2384745A3 (en) * 2010-05-05 2012-01-18 Sanovel Ilac Sanayi ve Ticaret A.S. Modified release pharmaceutical compositions of dexlansoprazole
US9795576B2 (en) * 2010-09-27 2017-10-24 Basf Se Protective coatings for acidic active ingredients
WO2012075309A1 (en) 2010-12-01 2012-06-07 Yale University Spin spray layer-by-layer assembly systems and methods
KR101875245B1 (en) 2010-12-02 2018-08-02 온콜리틱스 바이오테크 인코포레이티드 Liquid viral formulations
AU2012265842A1 (en) 2011-06-07 2014-01-23 SPAI Group Ltd. Compositions and methods for improving stability and extending shelf life of sensitive food additives and food products thereof
US20130323350A1 (en) * 2011-10-17 2013-12-05 Allen Seligson Orally dispersible multi-micronutrient dietary supplement composition and methods of using same
CN103251941A (en) 2012-02-16 2013-08-21 海南大学 Animal viral vaccine pulsatile release system, and preparation method and application thereof
IN2014DN10765A (en) 2012-05-30 2015-09-04 Univ California
ES2436249B1 (en) * 2012-06-25 2014-06-23 Javier Alberto ALONSO-VAQUERO VELASCO Antiparasitic composition for the control and treatment of parasites of different animal species, characterized by combining Moxidectin with vitamins: A, D3, and E
SG10201808645TA (en) * 2013-12-16 2018-11-29 Massachusetts Inst Technology Fortified Micronutrient Salt Formulations

Also Published As

Publication number Publication date
MX2016007786A (en) 2017-03-03
EP3082471B1 (en) 2017-10-04
US20150164816A1 (en) 2015-06-18
WO2015095185A1 (en) 2015-06-25
US20230372254A1 (en) 2023-11-23
CN106061292B (en) 2020-01-21
EP3082471A1 (en) 2016-10-26
ES2647791T3 (en) 2017-12-26
US20170216216A1 (en) 2017-08-03
US9649279B2 (en) 2017-05-16
CN106061292A (en) 2016-10-26
US11541017B2 (en) 2023-01-03
SG11201604805XA (en) 2016-07-28

Similar Documents

Publication Publication Date Title
SG10201808645TA (en) Fortified Micronutrient Salt Formulations
NZ596902A (en) Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders
WO2012085671A3 (en) Antioxidants in fish oil powder and tablets
WO2013049519A3 (en) Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols
NZ707192A (en) Microalgal flour granules and process for preparation thereof
JP2010275318A5 (en)
NZ707253A (en) Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life
MX2014004480A (en) Dietary supplements with rapid buccal dissolution.
SG10201609137PA (en) Gamma-polyglutamic acid and zinc compositions
WO2013057400A3 (en) Food product useful as a nutritional supplement or complete meal
SI2016838T1 (en) Food supplement
Lee Degradation of properties and loss of nutrients in gelatin soft capsules the manufacturing process
Lee et al. Effect of dietary Korean Traditional Fermented Foods with Processed Meat Products on the Occurrence of Carcinogens
Seol et al. The effect of the water extracts of digestive medicinal plants on the shelf-life of pork patties
Athawale et al. Formulation and Evaluation of Herbal Nutraceutical Tablets for Malnutrition
Asha et al. Encapsulated β-carotene and its use in nutrient formulations against malnutrition
Kim et al. Procyanidin Trimer C1 Inhibits LPS-Induced MAPK and NF-κB Signaling through TLR4 in Macrophages
CN102919527A (en) Animal feed
RU2012151044A (en) BIOLOGICALLY ACTIVE ADDITIVE
CN104256658A (en) Pollen pini compound food capable of improving immunity
PH22016000006U1 (en) Food supplement composition that target mother cells involved in abnormal cell growth
Kim The Antioxidant Activity of Maillard Reaction Products (MRPs) in Both Aqueous and Ethanolic Glucose-Glycine Oligomer Solutions
Lee et al. Monitoring of Anti-impotence Drugs, Anti-obesity Drugs and Their Analogues in Foods
LV14560A (en) Nutritional supplement containing salt of butanoic acid and polysaccharide composed of fructose, as well as administration form thereof
Nam et al. The Effects of Superjami bran on in vitro and in vivo antioxidative and bone mineral density activities in ovariectomized rats